11 January 2022
Drug reviews and drug licensing
Showing results 21 - 30 of 100
Sorted by most recent
19 August 2021
19 July 2021
26 November 2020
28 September 2020
27 March 2020
30 January 2020
27 November 2019
29 August 2019
25 July 2019
Validation period: 12/30/2024, 11:12:32 AM - 12/31/2024, 11:12:32 AM
Dapagliflozin no longer licensed for type 1 diabetes ▼Romosozumab for osteoporosis Chloramphenicol eye drops: ok to use in children younger than 2 years Esketamine for treatment-resistant depression Three new drugs for the prevention of migraine EMA suspends licence for ingenol mebutate (Picato) Melatonin for jet lag ▼Prasterone for vulvar and vaginal atrophy Naloxone nasal spray New restrictions and precautions for the use of fluoroquinolones